✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹96 Cr.
P/E
35.61
About
Sangani Hospitals Limited is a multi-specialty healthcare provider with two hospitals in Keshod and Veraval regions of Gujarat. Services range from super specialty to support services, including a pat… Read more
Sangani Hospitals Limited is a multi-specialty healthcare provider with two hospitals in Kesho… Read more
Low
35
52W Range
High
81
  • Sangani Hospitals
  • Fortis MalarHospital
  • Aspira Pathlab&Diagn

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

6 Yes

Positive for this company

3 Neutral

Neutral for this company

4 No

Negative for this company

4 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison
FAQs on Sangani Hospitals Ltd. Business

Sangani Hospitals Limited operates multi-specialty healthcare facilities in Keshod and Veraval, Gujarat. Offering a wide range of super specialty, specialty, and support services including pathology lab and medical store.

Sangani Hospitals major competitors are Fortis MalarHospital, Aspira Pathlab&Diagn, NG Industries, Aatmaj Healthcare, Transgene Biotek, Tejnaksh Healthcare, Lotus Eye Hospital.
Market Cap of Sangani Hospitals is ₹96 Crs.
While the median market cap of its peers are ₹60 Crs.

Sangani Hospitals seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Sep Jun Dec Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Investor Presentation Sep Jun Dec Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call Sep Jun Dec Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Sep Jun Dec Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Discussions & Analysis
[]